This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Updated from 3:42 p.m. EDT

Shares of Isis Pharmaceuticals (ISIS) were up 6.82% after the company announced that its phase I clinical trial of ISIS 301012, a cholesterol-reducing drug, produced rapid, dose-dependent and prolonged reductions of its target ApoB-100, while reducing LDL cholesterol and VLDL cholesterol levels.

The reductions occurred after one month of dosing and lasted more than 100 days. "ISIS 301012 is already showing the potential for an attractive profile, validating what we saw in preclinical studies, and we are excited about moving forward in clinical development," said Mark Wedal, vice president of clinical research and chief medical officer at Isis. The stock closed up 24 cents to $3.76.

Shares of Able Laboratories (ABRX) slid 7.39% after the company announced that it is making further staff reductions. The company did not specify how many workers it would be laying off. The company said the cuts would help "conserve assets and assist it in retaining key employees as it continues to address pending regulatory issues." Able previously suspended its manufacturing operations after discovering problems with them. The stock traded down 32 cents to $4.02.

Shares of Canadian health care provider MDS (MDZ) were up 0.21% after the company said it earned $30.24 million, or roughly 16 cents a share, for the second quarter ended April 30, compared with earnings of $51.73 million, or 19 cents, a year ago. Revenue for the quarter was $318.35 million, unchanged from a year ago. The stock traded up 13 cents to $14.38 after trading as low as $13.82 on the day.

CuraGen (CRGN) rose 6.82% after its majority owned subsidiary, 454 Life Sciences, reported that one of its scientists had detailed a potentially new application for the company's technology -- ultra-deep sequencing of the HIV virus. Identifying and understanding HIV drug resistance is necessary to ensure the appropriate use of antiretroviral drugs and to minimize the spread of resistance. The stock closed up 26 cents to $4.07.

Other health stocks on the move were Merck (MRK), down 28 cents to $31.35; Biogen Idec (BIIB), up $1.78 to $35.13; Elan (ELN), up 77 cents to $7.37; and Pfizer (PFE), down 12 cents to $27.53.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ALTI $0.25 66.67%
FB $117.98 -0.50%
GOOG $696.21 -0.29%
TSLA $236.77 -2.10%
YHOO $36.20 -0.90%


Chart of I:DJI
DOW 17,780.25 -110.91 -0.62%
S&P 500 2,065.22 -16.21 -0.78%
NASDAQ 4,778.7780 -38.8160 -0.81%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs